What is Elfun Government Valuation? (USA Stocks:ELMXX) - Macroaxis Elfun Government Money is fairly valued with Real Value of 0.99 and Hype Value of 1.0. Elfun Government's enterprise value overview and Elfun Government Money(ELMXX) SEC filings, reports, and corporate actions. Check Elfun Government's net worth. Elfun Government's valuation is the process of determining the intrinsic value of its stock by analyzing various financial and operational factors.

Elfun Government Valuation

ELMXX Fund   1.00  0.00  0.00%   
Today, the entity appears to be fairly valued. Elfun Government Money shows a prevailing Real Value of USD0.99 per share. The current price of the fund is USD1.0. Our model computes the value of Elfun Government Money from reviewing the entity technical indicators and probability of bankruptcy. In general, investors advise acquiring undervalued money market funds and dropping overvalued money market funds since, at some point, money market fund prices and their ongoing real values will submerge.

About Elfun Government Valuation

Our relative valuation model uses a comparative analysis of Elfun Government. We calculate exposure to Elfun Government's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Elfun Government's related companies.

Other Information on Investing in Elfun Money Market Fund

Elfun Government financial ratios help investors to determine whether Elfun Money Market Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Elfun with respect to the benefits of owning Elfun Government security.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance